Lupin - Lower Tax Saves Q4, Revenue Back Up Required For Sustained
Margin Improvement: Dolat Capital
The Lupin Ltd. pharmaceutical plant stands in Salcette, Goa. (Photographer: Dhiraj Singh/Bloomberg)

Lupin - Lower Tax Saves Q4, Revenue Back Up Required For Sustained Margin Improvement: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Lupin Ltd. reported an-in line Q4 adjusted for one-off in employee costs and lower tax rate (10% versus normal run-rate of 30%).

Sales were tepid, fell 1% YoY (all geographies soft except India), reported Ebitda margin at 19% and profit after tax of Rs 4.6 billion (we saw Rs 2.6 billion).

Key notable trend in the company has been the gradual improvement in Ebitda margin since past six quarters led by cost optimisation drive but has not been supported by revenue growth.

Click on the attachment to read the full report:

Dolat Capital Lupin Q4FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.